Prosecution Insights
Last updated: October 04, 2026

Smartfem Medical Technology Pty Ltd.

1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Smartfem Medical Technology Pty Ltd. has 1 pending office action. This action is being handled by 1 distinct examiner. The data reports 0 distinct art units for the company's current active portfolio. This centralized prosecution profile suggests that the company's immediate patent outcomes are tied to a single point of contact at the patent office.

Hu, Ann M is the busiest examiner for the portfolio, managing the pending office action. Because there is only the mentioned pending action in total, this examiner is responsible for the company's entire active prosecution. The focus on a single examiner suggests a centralized point of contact for the company's current legal matters, making the examiner's specific review patterns the primary factor in the company's immediate patent outcomes.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
100% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HU, ANN M 1 67.8% +21.6%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18688041 SCAFFOLD FOR SOFT TISSUE AUGMENTATION AND REINFORCEMENT HU, ANN M —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18688041 SCAFFOLD FOR SOFT TISSUE AUGMENTATION AND REINFORCEMENT HU, ANN M —

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18688041 SCAFFOLD FOR SOFT TISSUE AUGMENTATION AND REINFORCEMENT HU, ANN M — §103§112 Non-Final OA — Pending Feb 29, 2024

Managing Smartfem Medical Technology Pty Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month